Sanofi Launches Action 2016, a Worldwide Employee Stock Purchase Plan
(Thomson Reuters ONE) -
Sanofi Launches Action 2016,
a Worldwide Employee Stock Purchase Plan
Paris, France - June 9, 2016 - Sanofi announced today the launch of Action
2016, a worldwide stock purchase plan reserved for its employees. In doing such
a capital increase, Sanofi intends to better associate its employees with the
future development and results of the company. The plan will take place in more
than 90 countries.
On March 3, 2016 the Board of Directors authorized an issuance of ordinary
shares of Sanofi for the benefit of employees participating in the Group Savings
Plan. The subscription price is ?57.25. It is equal to 80 % of the average of
the opening price of the Sanofi share on Euronext Paris over the 20 stock
exchange trading sessions preceding June 8, 2016. Any subscription for a minimum
of five shares as part of such issuance shall entitle the employee to one
matching share. A subscription for ten shares at least or more shall give right
to two matching shares as an employer contribution. Employees may choose to
subscribe a maximum of 1,500 shares within the limit of a maximum subscription
amount which does not exceed 25% of their gross annual remuneration.
An eligibility condition of three months of seniority as at the closing date of
the subscription period will be applied. The subscription period will run from
June 13, 2016 (inclusive) until June 24, 2016 (inclusive).
The issuance of new shares and the share delivery process should occur by the
end of July 2016.
The total number of shares that may be issued under the plan is limited to 6.5
million shares (corresponding to a share capital increase in terms of par value
of up to ?13 million, representing 0.5 % of the share capital).
The newly issued shares, including the matching shares (the "Shares") will be
subscribed (or delivered) either directly or through employee shareholding funds
("FCPE"), depending on the legal and/or tax regulations applicable in the
various countries of residence of the beneficiaries of the capital increase.
The Shares will be fully fungible with the existing ordinary shares of Sanofi
and will be entitled to dividends distributed on benefits relating to the fiscal
year starting as of January 1, 2016.
The voting rights attached to the Shares subscribed will be directly exercised
by the employees.
The subscribers to the plan will be required to hold the Shares or the
corresponding "FCPE" units during a period of approximately five years, i.e.
until May 31, 2021, except upon the occurrence of an early exit event provided
in Article R. 3324-22 of the French Labor Code and authorized in the country of
the subscriber.
The listing of the Shares on the Euronext Paris market (ISIN Code: FR0000120578)
on the same listing line as the existing shares will be requested as soon as
possible after the completion of the capital increase.
This press release does not constitute an offer to sell or a solicitation to
purchase Sanofi shares. The offering of Sanofi shares reserved for employees
will be conducted only in countries where such an offering has been registered
or notified to the competent local authorities and/or following approval of a
prospectus by the competent local authorities or in consideration of an
exemption to prepare a prospectus or to make any registration or notification of
the offering, when such a procedure is required.
More generally, the offering will only be conducted in countries where all
required filing procedures and/or notifications have been completed and the
authorizations have been obtained, and procedures for consultation or
information of staff representatives have been fulfilled.
This press release is not intended for, and copies thereof should not be sent
to, countries in which such a prospectus has been approved or such an exemption
is not available or where all of the required filing procedures, notifications,
consultation and/or information required have been completed or where the
authorizations have been obtained. This applies in particular to Morocco, where
the formalities are still pending with the authorities, but could also involve
other countries.
For any questions related to the following share capital increase, each
beneficiary may consult the information booklet and all other documents made
available and/or contact his/her human resources manager.
This press release is made in reliance of the exemption from publishing a
prospectus provided for in Article 4(1)(e) of the EU Prospectus Directive
2003/71/EC, as amended. It constitutes the document required to qualify for the
exemption from the requirement to publish a prospectus as defined in the EU
Prospectus Directive 2003/71/EC, as amended, transposed in internal law of the
member states of the European Union and, with respect to French law, to Articles
212-4 (paragraph 5) and 212-5 (paragraph 6) of the AMF's General Regulations and
to Article14 of Instruction n°2005-11 of December 13, 2005, as well as the press
release required by the AMF in accordance with Article 223-2 of the AMF's
General Regulations.
About Sanofi
Sanofi, a global healthcare leader, discovers, develops and distributes
therapeutic solutions focused on patients' needs. Sanofi is organized into five
global business units: Diabetes and Cardiovascular, General Medicines and
Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in
Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
--------------------------------------------------------------------------------
Contacts:
Media Relations Investor Relations
Nicolas Kressmann George Grofik
Tel.: + (33) 1 53 77 46 46 Tel.: + (33) 1 53 77 45 45
mr(at)sanofi.com ir(at)sanofi.com
Press release:
http://hugin.info/152918/R/2018271/749396.pdf
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Sanofi via GlobeNewswire
[HUG#2018271]
Unternehmensinformation / Kurzprofil:
Datum: 09.06.2016 - 07:00 Uhr
Sprache: Deutsch
News-ID 476643
Anzahl Zeichen: 7283
contact information:
Town:
PARIS
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 289 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Sanofi Launches Action 2016, a Worldwide Employee Stock Purchase Plan"
steht unter der journalistisch-redaktionellen Verantwortung von
Sanofi (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
